PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17804225-1	2007	A successful design of conformationally restricted novel quinazolinone derivatives linked via a cyclopentene moiety as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors has been developed.	Cyclopentanes	96-108	poly(ADP-ribose) polymerase 1	Homo sapiens	126-154	
17804225-1	2007	A successful design of conformationally restricted novel quinazolinone derivatives linked via a cyclopentene moiety as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors has been developed.	Cyclopentanes	96-108	poly(ADP-ribose) polymerase 1	Homo sapiens	156-162	
33120078-3	2020	Constraining the linear propylene linker of structure I into a cyclopentene ring (II) offered improved PK parameters, while maintaining potency for PARP1.	Cyclopentanes	63-75	poly(ADP-ribose) polymerase 1	Homo sapiens	148-153